GPCR-targeted antibodies (Eloxx Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGPCR-targeted antibodies (Eloxx Pharmaceuticals)
Drug Alias NameGPCR-targeted antibodies (Senesco)GPCR-targeted antibodies (Sevion Therapeutics)uGPCR-targeted antibodies (Fabrus)
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionG-protein coupled receptor modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFabrus Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEloxx Pharmaceuticals IncFabrus Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A